학술논문

Non-pegylated and Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma and the Risk of Severe Ocular Side-effects.
Document Type
Case Study
Source
Acta Dermato-Venereologica. 2022, Vol. 102, p1-3. 3p.
Subject
*CUTANEOUS T-cell lymphoma
*INTERFERONS
*SEZARY syndrome
*RETINAL artery
*RETINAL vein occlusion
*RETINAL artery occlusion
*CHRONIC hepatitis C
Language
ISSN
0001-5555
Abstract
The article presents a study which compared the risk of severe ocular side-effects with cutaneous T-cell lymphomas (CTCLs) patients who received non-pegylated interferon alpha-2a (IFNα-2a). It mentions that the study aimed to increase the awareness of PEG-IFNα-2a-induced ocular side-effects in patients with CTCL.